{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:59:12Z","timestamp":1773500352694,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jid.2021.07.174","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T10:47:47Z","timestamp":1631702867000},"page":"624-632.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"PA","title":["Positive Allosteric Modulation of A2AR Alters Immune Cell Responses and Ameliorates Psoriasis-Like Dermatitis in Mice"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-0850","authenticated-orcid":false,"given":"Ajith","family":"Welihinda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-1711","authenticated-orcid":false,"given":"Puja","family":"Ravikumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9906-0112","authenticated-orcid":false,"given":"Manmeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3303-5571","authenticated-orcid":false,"given":"Jordan","family":"Mechanic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-9304","authenticated-orcid":false,"given":"Shruti","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5824-8012","authenticated-orcid":false,"given":"Gyeong Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-4503","authenticated-orcid":false,"given":"Edward","family":"Amento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.07.174_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jid.2021.07.174_bib2","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.07.174_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1574886310666151014115532","article-title":"Biologic therapy in psoriasis: safety profile","volume":"11","author":"Campanati","year":"2016","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.jid.2021.07.174_bib4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2174\/138161208784480081","article-title":"A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists","volume":"14","author":"Cristalli","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jid.2021.07.174_bib5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1096\/fj.11-190934","article-title":"Adenosine promotes alternative macrophage activation via A2A and A2B receptors","volume":"26","author":"Cs\u00f3ka","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.jid.2021.07.174_bib6","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/mol.104.007807","article-title":"Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1","volume":"67","author":"Desai","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jid.2021.07.174_bib7","doi-asserted-by":"crossref","first-page":"a015354","DOI":"10.1101\/cshperspect.a015354","article-title":"Psoriasis","volume":"4","author":"Di Meglio","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jid.2021.07.174_bib8","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archderm.140.12.1490","article-title":"Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors","volume":"140","author":"Gilliet","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2021.07.174_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/0091270007301620","article-title":"Regadenoson pharmacokinetics and tolerability in subjects with impaired renal function","volume":"47","author":"Gordi","year":"2007","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jid.2021.07.174_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd2638","article-title":"Adenosine receptors: therapeutic aspects for inflammatory and immune diseases","volume":"7","author":"Hask\u00f3","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2021.07.174_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1189\/jlb.0607359","article-title":"A2A receptors in inflammation and injury: lessons learned from transgenic animals","volume":"83","author":"Hask\u00f3","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jid.2021.07.174_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2021.07.174_bib13","doi-asserted-by":"crossref","first-page":"268257","DOI":"10.1155\/2014\/268257","article-title":"Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis","volume":"2014","author":"Hwang","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jid.2021.07.174_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrd1983","article-title":"Adenosine receptors as therapeutic targets","volume":"5","author":"Jacobson","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2021.07.174_bib15","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.07.174_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1124\/jpet.105.096016","article-title":"Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor","volume":"317","author":"Kreckler","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jid.2021.07.174_bib17","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1097\/00003246-200009000-00014","article-title":"High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock","volume":"28","author":"Martin","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jid.2021.07.174_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1096\/fj.05-4804fje","article-title":"Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils","volume":"20","author":"McColl","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.jid.2021.07.174_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1100\/tsw.2011.22","article-title":"Anti-inflammatory and immunosuppressive effects of the A2A adenosine receptor","volume":"11","author":"Milne","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jid.2021.07.174_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pbb.2008.01.006","article-title":"Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake","volume":"89","author":"Mingote","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jid.2021.07.174_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2021.07.174_bib23","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1172\/JCI61862","article-title":"Ror\u03b3t+ innate lymphocytes and \u03b3\u03b4 T cells initiate psoriasiform plaque formation in mice","volume":"122","author":"Pantelyushin","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2021.07.174_bib24","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/bjd.14164","article-title":"Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)","volume":"173","author":"Paul","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.07.174_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jlb.55.2.234","article-title":"Cytokine induction in mice by the immunomodulator imiquimod","volume":"55","author":"Reiter","year":"1994","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jid.2021.07.174_bib26","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.jid.5700286","article-title":"The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion","volume":"126","author":"Sch\u00f6n","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.07.174_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-5728(00)00365-9","article-title":"Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips","volume":"111","author":"Sperl\u00e1gh","year":"2000","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jid.2021.07.174_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084634","article-title":"Suppression of molecular inflammatory pathways by toll-like receptor 7, 8, and 9 antagonists in a model of IL-23-induced skin inflammation","volume":"8","author":"Su\u00e1rez-Fari\u00f1as","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2021.07.174_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2021.07.174_bib30","first-page":"168","article-title":"Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis","volume":"65","author":"Tian","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.jid.2021.07.174_bib31","article-title":"IFN-\u03b1 enhances IL-22 receptor expression in keratinocytes: a possible role in the development of psoriasis","volume":"32","author":"Tohyama","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.07.174_bib32","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1172\/JCI63451","article-title":"Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk","volume":"122","author":"Tortola","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2021.07.174_bib33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.1102224","article-title":"IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice","volume":"188","author":"Van Belle","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.07.174_bib34","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.07.174_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12950-014-0037-0","article-title":"Positive allosteric modulation of the adenosine A2a receptor attenuates inflammation","volume":"11","author":"Welihinda","year":"2014","journal-title":"J\u00a0Inflamm (Lond)"},{"key":"10.1016\/j.jid.2021.07.174_bib36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cellsig.2016.02.010","article-title":"The adenosine metabolite inosine is a functional agonist of the adenosine A2a receptor with a unique signaling bias","volume":"28","author":"Welihinda","year":"2016","journal-title":"Cell Signal"},{"key":"10.1016\/j.jid.2021.07.174_bib37","doi-asserted-by":"crossref","first-page":"10723","DOI":"10.1073\/pnas.1307569110","article-title":"Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice","volume":"110","author":"Wohn","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.07.174_bib38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11655-014-1792-0","article-title":"Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes","volume":"21","author":"Xuan","year":"2015","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.jid.2021.07.174_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40257-020-00578-0","article-title":"Use of IL-23 inhibitors for the treatment of plaque psoriasis and psoriatic arthritis: a comprehensive review","volume":"22","author":"Yang","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2021.07.174_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2007-03-081646","article-title":"A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy\u00a0and the generation of adaptive regulatory T cells","volume":"111","author":"Zarek","year":"2008","journal-title":"Blood"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21021643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21021643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:26:27Z","timestamp":1758302787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X21021643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022202X21021643"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.07.174","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive Allosteric Modulation of A2AR Alters Immune Cell Responses and Ameliorates Psoriasis-Like Dermatitis in Mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.07.174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}